US10016455B2ExpiredUtilityA1

Method of preventing or treating influenza with oxidative reductive potential water solution

Assignee: SONOMA PHARMACEUTICALS INCPriority: Dec 30, 2003Filed: May 9, 2017Granted: Jul 10, 2018
Est. expiryDec 30, 2023(expired)· nominal 20-yr term from priority
Inventors:Hojabr Alimi
A61L 2103/15A61L 2/18A61L 2103/05A61K 33/20A61K 9/0019A61K 33/40A61K 47/32A61L 2/0088A61K 45/06A61K 9/007C02F 1/4618A61L 2/035C02F 1/4672A61L 2/186C02F 2201/4618C02F 2303/04C02F 2103/026A61L 2202/17A01N 59/00C02F 1/722C02F 1/76A61K 9/0014A61L 2/22A61L 2202/122Y02A50/30C02F 2001/46195C02F 2201/46115C02F 2209/40C02F 1/4674A61K 33/00A61L 2202/11C02F 2209/06C02F 2209/04
81
PatentIndex Score
2
Cited by
555
References
5
Claims

Abstract

Provided is a method for preventing or treating influenza by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers. The ORP water solution can be administered alone or, e.g., in combination with one or more additional therapeutic agents.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method of treating or preventing a viral infection in a patient comprising administering a therapeutically effective amount of an oxidative reductive potential water solution to an infectious virus present on a surface of a tissue, wherein the infectious virus is an influenza virus, wherein the solution comprises about 10 ppm to about 400 ppm of free chlorine species selected from hypochlorous acid, hypochlorite ions, sodium hypochlorite, chlorite ions, chloride ion, chlorine dioxide, dissolved chlorine gas, and mixtures thereof, wherein the solution comprises a mixture of anode water and cathode water, the pH of the ORP water solution is between about 6.2 and about 7.8, and wherein the solution is stable for at least two months, wherein the solution is administered by aerosolization, nebulization and atomization. 
     
     
       2. The method of  claim 1 , wherein the influenza virus is an influenza A virus. 
     
     
       3. The method of  claim 1 , wherein the solution comprises about 50 ppm to about 200 ppm of free chlorine species. 
     
     
       4. The method of  claim 3 , wherein the free chlorine species comprises from about 15 ppm to about 35 ppm of hypochlorous acid and from about 25 ppm to about 50 ppm of sodium hypochlorite. 
     
     
       5. The method of  claim 1 , wherein the solution comprises from about 10% by volume to about 50% by volume of cathode water and from about 50% by volume to about 90% by volume of anode water.

Join the waitlist — get patent alerts

Track US10016455B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.